SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-023853
Filing Date
2015-01-28
Accepted
2015-01-28 17:19:10
Documents
3
Period of Report
2015-01-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d860446d8k.htm 8-K 15197
2 EX-5.1 d860446dex51.htm EX-5.1 7293
3 GRAPHIC g860446g07m01.jpg GRAPHIC 8552
  Complete submission text file 0001193125-15-023853.txt   35544
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34637 | Film No.: 15555745
SIC: 2834 Pharmaceutical Preparations